Active, not recruitingNot applicableNCT05741944
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients
Studying Soft tissue sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leiden University Medical Center
- Principal Investigator
- Leti van Bodegom-Vos, PhDLUMC
- Intervention
- Care with the use of PERSARC(other)
- Enrollment
- 120 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2025
Study locations (7)
- Radboud UMC, Nijmegen, Gelderland, Netherlands
- Maastricht UMC, Maastricht, Limburg, Netherlands
- Netherlands Cancer Institue, Amsterdam, North Holland, Netherlands
- UMC Groningen, Groningen, Provincie Groningen, Netherlands
- Leiden University Medical Center, Leiden, South Holland, Netherlands
- Erasmus MC, Rotterdam, South Holland, Netherlands
- UMC Utrecht, Utrecht, Utrecht, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05741944 on ClinicalTrials.govOther trials for Soft tissue sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07402577Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility StudyRoswell Park Cancer Institute
- RECRUITINGNANCT07359911Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma PatientsUniversity of Miami
- RECRUITINGNCT07148193Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)Technische Universität Dresden
- RECRUITINGPHASE1NCT07156565Actinium Therapy for Late-stage Aggressive SarcomasRatio Therapeutics, Inc.
- RECRUITINGNANCT07104955Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and SafetySalutare Group Ltd.
- RECRUITINGPHASE1, PHASE2NCT07064018Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesUniversity of California, Irvine
- RECRUITINGNCT06962072Outcomes Following Limb Sparing Surgery for Soft Tissue SarcomaAmsterdam UMC
- RECRUITINGPHASE2NCT06905132Preoperative 5-Day Radiotherapy for Soft Tissue SarcomaMedical University of South Carolina